USPTO Examiner DEL PRIORE ALESSANDRO R - Art Unit 3781

Recent Applications

Detailed information about the 100 most recent patent applications.

Application NumberTitleFiling DateDisposal DateDispositionTime (months)Office ActionsRestrictionsInterviewAppeal
19216510METHOD OF REDUCING LEFT ATRIAL PRESSUREMay 2025July 2025Allow200YesNo
19043551CONNECTOR FOR A MEDICAL CONTAINERFebruary 2025April 2025Allow300YesNo
18667848HERNIA BELT SYSTEMSMay 2024August 2025Abandon1510YesNo
18596620Effervescent Foot Bath and MethodMarch 2024May 2025Allow1410YesNo
18429963EXTRACORPOREAL AMBULATORY ASSIST LUNGFebruary 2024January 2026Abandon2320YesNo
18530657COMPONENT POSITIONING AND STRESS RELIEF FOR SENSOR ENABLED WOUND DRESSINGSDecember 2023January 2025Allow1300YesNo
18287856COMMUNICATION SYSTEMS AND METHODS FOR NEGATIVE PRESSURE WOUND THERAPY DEVICESOctober 2023January 2026Allow2710YesNo
18227743METHOD OF TREATING NORMAL PRESSURE HYDROCEPHALUSJuly 2023June 2024Allow1100YesNo
18222530METHOD OF PROVIDING A SIGNAL TO ALERT AN OSTOMATE OF AN IMMINENT LEAKAGE OF STOMA FLUIDSJuly 2023September 2024Allow1410NoNo
18217804CONNECTOR FOR A MEDICAL CONTAINERJuly 2023September 2024Allow1510YesNo
18202010AV FLOW RESTRICTORSMay 2023November 2025Allow2940YesNo
18253856ABSORBENT ARTICLE WITH IMPROVED CAPILLARY ACCELERATION SHEETMay 2023October 2025Allow2900YesNo
18311673MULTI-DOSE OCULAR FLUID DELIVERY SYSTEMMay 2023July 2025Allow2720YesNo
18194700ENDOSCOPIC MEDICAL DEVICE FOR DISPENSING MATERIALS AND METHOD OF USEApril 2023October 2025Allow3010NoNo
18247608CLOSED LOOP, BEDSIDE CELL PURIFICATION SYSTEMS AND METHODSMarch 2023November 2025Allow3201YesNo
18180083FLOW MODIFICATION IN BODY LUMENSMarch 2023April 2024Allow1410YesNo
18158498Female Urethral Catheterization Assist DeviceJanuary 2023January 2025Allow2300NoNo
18007564METHOD FOR DISCONNECTIONDecember 2022May 2025Allow3000YesNo
17991950WOUND CLOSURE SYSTEM HAVING MICROCANNULAIC PATHWAYSNovember 2022March 2026Allow3911YesNo
17998955MOBILE NEGATIVE PRESSURE WOUND THERAPY DEVICENovember 2022November 2025Allow3620NoNo
17986588WOUND CONTACTING MEMBERS AND METHODSNovember 2022January 2026Abandon3840YesNo
18053335ENDOVASCULAR IMPLANTS AND DEVICES AND METHODS FOR ACCURATE PLACEMENTNovember 2022October 2023Allow1211YesNo
18051004AUTOIMMUNE MECHANICAL IMMUNOMODULATIONOctober 2022June 2024Allow1910YesNo
17947836EXPANDABLE AND RETRACTABLE MENSTRUAL CUPSeptember 2022June 2024Abandon2110NoNo
17901699FLUIDIC CONNECTOR FOR IRRIGATION AND ASPIRATION OF WOUNDSSeptember 2022January 2026Allow4140YesNo
17908484DEVICE AND METHOD FOR MONITORING COMPLIANCE WITH A THERAPEUTIC OPHTHALMIC TREATMENTAugust 2022January 2026Allow4120YesNo
17893435Automated Urine Output System for Attachment to Hospital BedAugust 2022July 2025Allow3510YesNo
17800368Adaptor for Mounting onto a Medical Container, a Medical Container Comprising Said Adaptor, and a Drug Delivery Device Comprising Said Medical ContainerAugust 2022May 2025Allow3310YesNo
17797070A MULTI-LUMEN IMPLANTABLE DEVICEAugust 2022January 2026Allow4121NoNo
17877727HEMODIALYSIS CATHETER WITH CORRUGATED TIPSJuly 2022March 2024Allow2010NoNo
17805896CANNULAS FOR OPHTHALMIC PROCEDURESJune 2022August 2024Allow2611YesNo
17804182DISPOSABLE URINE COLLECTION CONTAINERMay 2022February 2025Allow3310YesNo
17747344DEVICES, SYSTEMS, AND METHODS FOR ADJUSTING A PASSAGE THROUGH AN IMPLANTABLE DEVICEMay 2022March 2025Allow3421YesNo
17744127TRANSCATHETER MEDICAL IMPLANT DELIVERYMay 2022February 2025Allow3320YesNo
17739019METHODS AND APPARATUS FOR A STOMA COVERING DEVICEMay 2022December 2024Allow3240YesNo
17733945SMART ABSORBENT ARTICLE, COMPONENTS, AND PROCESS OF MAKINGApril 2022June 2024Abandon2601NoNo
17721830MEDICAL CONTAINER WITH NFC ANTENNAApril 2022March 2024Allow2310YesNo
17721493EXPANDABLE AND RETRACTABLE MENSTRUAL CUPApril 2022June 2022Allow200YesNo
17762698APPARATUSES AND METHODS FOR NEGATIVE PRESSURE WOUND THERAPYMarch 2022December 2024Allow3310YesNo
17630785CATHETER SYSTEMS AND METHODSJanuary 2022July 2024Allow3000NoNo
17626041DEVICES AND METHODS FOR TREATING OCULAR CONDITIONSJanuary 2022March 2025Abandon3810NoNo
17567454Effervescent Foot Bath and MethodJanuary 2022September 2023Abandon2110NoNo
17560218MANUALLY ADJUSTABLE INTRAOCULAR FLOW REGULATIONDecember 2021October 2024Abandon3411NoNo
17536834CONTROLLED EXTENSION STENTNovember 2021May 2024Allow2920NoNo
17529330ASSEMBLY WITH CONNECTABLE AND DISCONNECTABLE ELEMENTS FOR THE RECONSTITUTION OF FLUID DRUGS AND NUTRIENTS WITH ACTIVE SUBSTANCES IN POWDER, LIQUID OR GEL FORM, AND RELATED METHOD OF USENovember 2021September 2023Allow2200YesNo
17518189EMSIS BAGNovember 2021March 2024Abandon2810NoNo
17512464ENDOVASCULAR IMPLANTS AND DEVICES AND METHODS FOR ACCURATE PLACEMENTOctober 2021August 2022Allow911YesNo
17511238Treatment for Dry EyesOctober 2021March 2024Abandon2810YesNo
17599855Low Profile Instillation And Negative-Pressure BridgeSeptember 2021November 2024Allow3720YesNo
17463888SURGICAL DRAIN SYSTEM AND METHOD OF USESeptember 2021February 2024Allow3020YesNo
17444517ODOR/TOXIN-ABSORBING SANITARY PADS, PANTY LINERS, AND TAMPONSAugust 2021February 2024Abandon3110NoNo
17374856DEVICE FOR EXTRACORPOREAL BLOOD TREATMENTJuly 2021November 2024Abandon4010NoNo
17346313ARTICLE SIZE CHANGE FORECASTINGJune 2021March 2024Abandon3301NoNo
17335584Ostomy PouchJune 2021June 2025Allow4921NoNo
17335446Ostomy PouchJune 2021August 2025Allow5130NoNo
17329323NPWT MODULEMay 2021August 2024Abandon3930YesNo
17328049EXTRACORPOREAL AMBULATORY ASSIST LUNGMay 2021October 2023Allow2910YesNo
17295613COMPONENT MIXING DEVICE AND COMPONENT MIXING METHODMay 2021September 2024Abandon4001NoNo
17322981OXYGENATORMay 2021February 2024Allow3300NoNo
17292979WOUND THERAPY SYSTEM WITH BLOCKAGE AND LEAK DETECTIONMay 2021February 2026Allow5751NoNo
17236902APPLICATORApril 2021September 2023Abandon2910NoNo
17285320MICRO BALLOON-ON-TUBE WOUND FILLERApril 2021January 2024Abandon3310NoNo
17204344CONTAINER SYSTEM AND METHODMarch 2021December 2023Abandon3310NoNo
17275507SYSTEMS, APPARATUSES, AND METHODS FOR NEGATIVE-PRESSURE TREATMENT WITH REDUCED TISSUE IN-GROWTHMarch 2021October 2023Abandon3110NoNo
17198667ION EXCHANGE ENHANCED ABSORBENT SYSTEMSMarch 2021March 2025Abandon4841YesNo
17191239APPARATUS FOR DRAINING LYMPH INTO VEINSMarch 2021July 2024Abandon4130NoNo
17189393Vomit Bag with Anti-nausea Aroma DispenserMarch 2021June 2023Allow2810NoNo
17269395NEGATIVE PRESSURE WOUND THERAPY DEVICE STATUS INDICATION USING A CANISTERFebruary 2021September 2024Allow4340YesNo
17173729SYSTEMS AND METHODS FOR OXYGENATOR PERFORMANCE EVALUATIONFebruary 2021March 2025Allow4930YesNo
17151736Ostomy Garment AssemblyJanuary 2021January 2024Abandon3620NoNo
17258360ABDOMINAL DRESSING WITH USER SELECTION OF FASCIAL CLOSURE FORCE PROFILEJanuary 2021December 2024Allow4741YesNo
17127584Vented Multi-dose Ocular Fluid Delivery SystemDecember 2020December 2023Allow3610NoNo
17119905SYSTEMS AND DEVICES FOR DELIVERING FLUIDS TO THE EYE AND METHODS OF USEDecember 2020July 2024Allow4311YesNo
17119027DEVICES AND METHODS FOR THE CREATION OF AN INTER-ATRIAL SHUNT FOR THE TREATMENT OF CONGESTIVE HEART FAILUREDecember 2020August 2025Abandon5641NoNo
17104574COMPONENTS OF A FLUID TRANSFER APPARATUSNovember 2020May 2023Allow3010YesNo
17062063OSTOMY APPLIANCEOctober 2020October 2025Allow6040YesNo
17061732OSTOMY APPLIANCEOctober 2020February 2023Allow2920YesNo
16981958LIQUID FLOW DETECTION IN TISSUE SITE DRESSINGS AND INSTILLATION METHODSSeptember 2020February 2025Abandon5351YesNo
16979529APPARATUS AND METHODS FOR DETERMINING A MEDICAL APPLIANCE WEAR TIME BASED ON SENSOR DATASeptember 2020September 2025Allow6040YesNo
16979527APPARATUS AND METHODS FOR DETERMINING MEDICAL APPLIANCE WEAR TIME BASED ON LOCATION DATASeptember 2020June 2025Allow5840YesNo
17002299DRUG TRANSFER ADAPTERAugust 2020February 2023Allow3030NoNo
16991669FORWARD OSMOSIS MEDICAL AND WOUND CARE DEVICESAugust 2020December 2022Allow2820NoNo
16983738FOOT PATCHAugust 2020June 2023Abandon3401NoNo
16966531LIQUID MEDICINE ADMINISTRATION IDENTIFYING DEVICE AND LIQUID MEDICINE ADMINISTRATION IDENTIFYING SYSTEM USING SAMEJuly 2020March 2025Abandon5570YesNo
16916327LEG STRAP ASSEMBLY FOR A URINE BAGJune 2020December 2022Allow3030YesNo
16955066BASE PLATE AND SENSOR ASSEMBLY PART OF A MEDICAL SYSTEM HAVING A MOISTURE SENSORJune 2020October 2025Allow6040YesNo
16896957METHOD OF TREATING NORMAL PRESSURE HYDROCEPHALUSJune 2020April 2023Allow3410NoNo
16769175URINARY CATHETERS INCLUDING MECHANICAL PROPERTIES THAT ARE STABLE OVER A RANGE OF TEMPERATURESJune 2020November 2025Abandon6040NoNo
16757678FLUID SUPPLY UNIT, AND MICRO-DROPLET EJECTION DRIVING DEVICE AND GENERATING DEVICEMay 2020December 2023Abandon4421NoNo
16878589Drug Delivery Device and System with Metered Dosing for Semi-Solid CompositionsMay 2020February 2023Abandon3301NoNo
16764272FLUID COLLECTION APPARATUSMay 2020April 2023Allow3510YesNo
16761821KIT OF PARTS AND A COMPLEMENTARY-MATERIAL ELEMENT FOR AN OSTOMY APPLIANCEMay 2020October 2022Allow2920YesNo
16846491STEAM THERAPY APPARATUSApril 2020January 2024Abandon4510NoNo
16826483ENDOTRACHEAL DEVICES AND METHODS FOR USING AN ENDOTRACHEAL DEVICEMarch 2020November 2023Abandon4311NoNo
16813877ENTEROSTOMY DRAINAGE METHODS AND DEVICESMarch 2020January 2023Allow3520YesNo
16811879MULTI-DOSE OCULAR FLUID DELIVERY SYSTEMMarch 2020August 2022Allow2920YesNo
16799950STERILE AND STERILIZED PACKAGE FOR ADMINISTRATION OF MEDICINAL OR NUTRITIONAL SUBSTANCESFebruary 2020April 2024Allow5050YesNo
16789023DIAPER NOTIFICATION SYSTEMFebruary 2020August 2022Allow3001YesNo
16775681Hernia Belt SystemsJanuary 2020June 2024Abandon5340NoNo
16623855Transfer Device for Fluid TransmissionDecember 2019September 2022Allow3320NoNo

Appeals Overview

This analysis examines appeal outcomes and the strategic value of filing appeals for examiner DEL PRIORE, ALESSANDRO R.

Patent Trial and Appeal Board (PTAB) Decisions

Total PTAB Decisions
8
Examiner Affirmed
4
(50.0%)
Examiner Reversed
4
(50.0%)
Reversal Percentile
79.3%
Higher than average

What This Means

With a 50.0% reversal rate, the PTAB reverses the examiner's rejections in a meaningful percentage of cases. This reversal rate is in the top 25% across the USPTO, indicating that appeals are more successful here than in most other areas.

Strategic Value of Filing an Appeal

Total Appeal Filings
15
Allowed After Appeal Filing
6
(40.0%)
Not Allowed After Appeal Filing
9
(60.0%)
Filing Benefit Percentile
67.5%
Higher than average

Understanding Appeal Filing Strategy

Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.

In this dataset, 40.0% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is above the USPTO average, suggesting that filing an appeal can be an effective strategy for prompting reconsideration.

Strategic Recommendations

Appeals to PTAB show good success rates. If you have a strong case on the merits, consider fully prosecuting the appeal to a Board decision.

Filing a Notice of Appeal is strategically valuable. The act of filing often prompts favorable reconsideration during the mandatory appeal conference.

Examiner DEL PRIORE, ALESSANDRO R - Prosecution Strategy Guide

Executive Summary

Examiner DEL PRIORE, ALESSANDRO R works in Art Unit 3781 and has examined 166 patent applications in our dataset. With an allowance rate of 53.6%, this examiner allows applications at a lower rate than most examiners at the USPTO. Applications typically reach final disposition in approximately 40 months.

Allowance Patterns

Examiner DEL PRIORE, ALESSANDRO R's allowance rate of 53.6% places them in the 15% percentile among all USPTO examiners. This examiner is less likely to allow applications than most examiners at the USPTO.

Office Action Patterns

On average, applications examined by DEL PRIORE, ALESSANDRO R receive 2.43 office actions before reaching final disposition. This places the examiner in the 70% percentile for office actions issued. This examiner issues a slightly above-average number of office actions.

Prosecution Timeline

The median time to disposition (half-life) for applications examined by DEL PRIORE, ALESSANDRO R is 40 months. This places the examiner in the 25% percentile for prosecution speed. Applications take longer to reach final disposition with this examiner compared to most others.

Interview Effectiveness

Conducting an examiner interview provides a +48.8% benefit to allowance rate for applications examined by DEL PRIORE, ALESSANDRO R. This interview benefit is in the 92% percentile among all examiners. Recommendation: Interviews are highly effective with this examiner and should be strongly considered as a prosecution strategy. Per MPEP § 713.10, interviews are available at any time before the Notice of Allowance is mailed or jurisdiction transfers to the PTAB.

Request for Continued Examination (RCE) Effectiveness

When applicants file an RCE with this examiner, 22.9% of applications are subsequently allowed. This success rate is in the 30% percentile among all examiners. Strategic Insight: RCEs show below-average effectiveness with this examiner. Carefully evaluate whether an RCE or continuation is the better strategy.

After-Final Amendment Practice

This examiner enters after-final amendments leading to allowance in 14.3% of cases where such amendments are filed. This entry rate is in the 15% percentile among all examiners. Strategic Recommendation: This examiner rarely enters after-final amendments compared to other examiners. You should generally plan to file an RCE or appeal rather than relying on after-final amendment entry. Per MPEP § 714.12, primary examiners have discretion in entering after-final amendments, and this examiner exercises that discretion conservatively.

Pre-Appeal Conference Effectiveness

When applicants request a pre-appeal conference (PAC) with this examiner, 40.0% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 38% percentile among all examiners. Note: Pre-appeal conferences show below-average success with this examiner. Consider whether your arguments are strong enough to warrant a PAC request.

Appeal Withdrawal and Reconsideration

This examiner withdraws rejections or reopens prosecution in 55.6% of appeals filed. This is in the 28% percentile among all examiners. Of these withdrawals, 40.0% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner shows below-average willingness to reconsider rejections during appeals. Be prepared to fully prosecute appeals if filed.

Petition Practice

When applicants file petitions regarding this examiner's actions, 59.3% are granted (fully or in part). This grant rate is in the 63% percentile among all examiners. Strategic Note: Petitions show above-average success regarding this examiner's actions. Petitionable matters include restriction requirements (MPEP § 1002.02(c)(2)) and various procedural issues.

Examiner Cooperation and Flexibility

Examiner's Amendments: This examiner makes examiner's amendments in 0.0% of allowed cases (in the 46% percentile). This examiner makes examiner's amendments less often than average. You may need to make most claim amendments yourself.

Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.0% of allowed cases (in the 49% percentile). This examiner issues Quayle actions less often than average. Allowances may come directly without a separate action for formal matters.

Prosecution Strategy Recommendations

Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:

  • Prepare for rigorous examination: With a below-average allowance rate, ensure your application has strong written description and enablement support. Consider filing a continuation if you need to add new matter.
  • Prioritize examiner interviews: Interviews are highly effective with this examiner. Request an interview after the first office action to clarify issues and potentially expedite allowance.
  • Plan for RCE after final rejection: This examiner rarely enters after-final amendments. Budget for an RCE in your prosecution strategy if you receive a final rejection.
  • Plan for extended prosecution: Applications take longer than average with this examiner. Factor this into your continuation strategy and client communications.

Relevant MPEP Sections for Prosecution Strategy

  • MPEP § 713.10: Examiner interviews - available before Notice of Allowance or transfer to PTAB
  • MPEP § 714.12: After-final amendments - may be entered "under justifiable circumstances"
  • MPEP § 1002.02(c): Petitionable matters to Technology Center Director
  • MPEP § 1004: Actions requiring primary examiner signature (allowances, final rejections, examiner's answers)
  • MPEP § 1207.01: Appeal conferences - mandatory for all appeals
  • MPEP § 1214.07: Reopening prosecution after appeal

Important Disclaimer

Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.

No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.

Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.

Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.